Crucial cross-talk of interleukin-1β and progesterone in human choriocarcinoma

International Journal of Oncology

Volumn 40, Issue 5, 2012, Pages 1358-1364

  Zachariades, Elena ^a   Mparmpakas, Dionisis ^a   Thomas, Peter ^b   Rand Weaver, Mariann ^a   Karteris, Emmanouil ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Choriocarcinoma; Interleukin 1 ; Progesterone; Progesterone receptor

Indexed keywords

INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROGESTERONE; UO 126;

ARTICLE; CANCER CELL; CELL DEATH; CHORIOCARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

BUTADIENES; CELL DEATH; CELL LINE, TUMOR; CHORIOCARCINOMA; FEMALE; HUMANS; INTERLEUKIN-1BETA; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; PHOSPHORYLATION; PREGNANCY; PROGESTERONE; PROMEGESTONE; PROTEIN KINASE INHIBITORS; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR MICROENVIRONMENT; UTERINE NEOPLASMS;

EID: 84860280498     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1349     Document Type: Article

References (30)

1. Shih IM: Gestational trophoblastic neoplasia - pathogenesis and potential therapeutic targets. Lancet Oncol 8: 642-650, 2007.
2. Fulop V, Mok SC, Genest DR, Gati I, Doszpod J and Berkowitz RS: p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med 43: 119-127, 1998. (Pubitemid 28103575)
3. Fulop V, Mok SC, Genest DR, Szigetvari I, Cseh I and Berkowitz RS: c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med 43: 101-110, 1998. (Pubitemid 28103573)
4. Landers JE, Haines DS, Strauss JF III and George DL: Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells. Oncogene 9: 2745-2750, 1994. (Pubitemid 24254055)
5. Asanoma K, Matsuda T, Kondo H, Kato K, Kishino T, Niikawa N, Wake N and Kato H: NECC1, a candidate choriocarcinoma suppressor gene that encodes a homeodomain consensus motif. Genomics 81: 15-25, 2003. (Pubitemid 36263355)
6. Shaarawy M and Darwish NA: Serum cytokines in gestational trophoblastic diseases. Acta Oncol 34: 177-182, 1995.
7. Kobayashi S, Stice JP, Kazmin D, Wittmann BM, Kimbrel EA, Edwards DP, Chang CY and McDonnell DP: Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer. Mol Endocrinol 24: 2292-2302, 2010.
8. Hardy DB, Janowski BA, Corey DR and Mendelson CR: Progesterone receptor plays a major anti-inflammatory role in human myometrial cells by antagonism of nuclear factor-kappaB activation of cyclooxygenase 2 expression. Mol Endocrinol 20: 2724-2733, 2006. (Pubitemid 44834326)
9. Hardy DB, Janowski BA, Chen CC and Mendelson CR: Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms. Mol Endocrinol 22: 1812-1824, 2008.
10. Davies S, Dai D, Wolf DM and Leslie KK: Immunomodulatory and transcriptional effects of progesterone through progesterone A and B receptors in Hec50co poorly differentiated endometrial cancer cells. J Soc Gynecol Investig 11: 494-499, 2004. (Pubitemid 39349203)
11. Jin L, Yuan RQ, Fuchs A, Yao Y, Joseph A, Schwall R, Schnitt SJ, Guida A, Hastings HM, Andres J, Turkel G, Polverini PJ, Goldberg ID and Rosen EM: Expression of interleukin-1beta in human breast carcinoma. Cancer 80: 421-434, 1997. (Pubitemid 27323412)
12. Zachariades E, Foster H, Goumenou A, Thomas P, Rand-Weaver M and Karteris E: Expression of membrane and nuclear progesterone receptors in two human placental choriocarcinoma cell lines (JEG-3 and BeWo): Effects of syncytialization. Int J Mol Med 27: 767-774, 2011.
13. Cheung AN, Zhang HJ, Xue WC and Siu MK: Pathogenesis of choriocarcinoma: clinical, genetic and stem cell perspectives. Future Oncol 5: 217-231, 2009.
14. Romero R, Wu YK, Brody DT, Oyarzun E, Duff GW and Durum SK: Human decidua: a source of interleukin-1. Obstet Gynecol 73: 31-34, 1989. (Pubitemid 19021000)
15. Librach CL, Feigenbaum SL, Bass KE, Cui TY, Verastas N, Sadovsky Y, Quigley JP, French DL and Fisher SJ: Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J Biol Chem 269: 17125-17131, 1994.
16. Yagel S, Lala PK, Powell WA and Casper RF: Interleukin-1 stimu-lates human chorionic gonadotropin secretion by first trimester human trophoblast. J Clin Endocrinol Metab 68: 992-995, 1989. (Pubitemid 19127422)
17. Seki H, Zosmer A, Elder MG and Sullivan MHF: The regulation of progesterone and hCG production from placental cells by interleukin-1β. Biochim Biophys Acta 1336: 342-348, 1997. (Pubitemid 27364190)
18. Nilkaeo A and Bhuvanath S: Interleukin-1 modulation of human placental trophoblast proliferation. Mediators Inflamm 2006: 79359, 2006.
19. Peluso JJ and Pappalardo A: Progesterone mediates its anti-mitogenic and anti-apoptotic actions in rat granulosa cells through a progesterone-binding protein with gamma aminobutyric acida receptor-like features. Biol Reprod 58: 1131-1137, 1998. (Pubitemid 28217235)
20. Berg MN, Dharmarajan AM and Waddell BJ: Glucocorticoids and progesterone prevent apoptosis in the lactating rat mammary gland. Endocrinology 143: 222-227, 2002. (Pubitemid 34056423)
21. Dawood MY: Serum progesterone and serum human chorionic gonadotropin in gestational and nongestational choriocarcinoma. Am J Obstet Gynecol 123: 762-765, 1975.
22. Burleigh DW, Kendziorski CM, Choi YJ, Grindle KM, Grendell RL, Magness RR and Golos TG: Microarray analysis of BeWo and JEG3 trophoblast cell lines: identification of differentially expressed transcripts. Placenta 28: 383-389, 2007. (Pubitemid 46593757)
23. Lewis TS, Shapiro PS and Ahn NG: Signal transduction through MAP kinase cascades. Adv Cancer Res 74: 49-139, 1998. (Pubitemid 28193546)
24. Daoud G, Amyot M, Rassart E, Masse A, Simoneau L and Lafond J: ERK1/2 and p38 regulate trophoblasts differentiation in human term placenta. J Physiol 566: 409-423, 2005. (Pubitemid 41030549)
25. Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, Gong W, Beato M and Auricchio F: Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 17: 2008-2018, 1998. (Pubitemid 28154530)
26. Zhu Y, Bond J and Thomas P: Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA 100: 2237-2242, 2003. (Pubitemid 36297483)
27. Meyer C, Schmid R, Scriba PC and Wehling M: Purification and partial sequencing of high-affinity progesterone-binding site(s) from porcine liver membranes. Eur J Biochem 239: 726-731, 1996. (Pubitemid 26253047)
28. Neubauer H, Yang Y, Seeger H, Fehm T, Cahill MA, Tong X, Ruan X and Mueck AO: The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells. Menopause 18: 845-850, 2011.
29. Ahmed IS, Rohe HJ, Twist KE, Mattingly MN and Craven RJ: Progesterone receptor membrane component 1 (PGRMC-1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule. J Pharmacol Exp Ther 333: 564-573, 2010.
30. Dressing GE, Pang Y, Dong J and Thomas P: Progestin signaling through mPRα in Atlantic croaker granulosa/theca cell cocultures and its involvement in progestin inhibition of apoptosis. Endocrinology 151: 5916-5926, 2010.